ELENA SHUMSKY: Open Payments
NPI 1427224237 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,689 in 65 payments from 21 companies in 2025. Trend: 2023 $2,104 · 2024 $2,041 · 2025 $1,689
Food & beverage: $1,529Education: $160
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $350 |
| Janssen Scientific Affairs, LLC | 2 | $262 |
| ABBVIE INC. | 13 | $174 |
| GENZYME CORPORATION | 6 | $153 |
| REVANCE THERAPEUTICS, INC. | 1 | $148 |
| Novartis Pharmaceuticals Corporation | 4 | $109 |
| Regeneron Healthcare Solutions, Inc. | 2 | $77 |
| Lilly USA, LLC | 3 | $72 |
| PFIZER INC. | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
Products named: TREMFYA, DUPIXENT, DAXI, RINVOQ, COSENTYX, SKYRIZI, LITFULO, EBGLYSS.
Industry payments across FL — which companies pay providers there.
